VERA - Vera Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$76.40
DETAILS
HIGH:
$95.00
LOW:
$33.00
MEDIAN:
$90.00
CONSENSUS:
$76.40
UPSIDE:
124.44%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 13.64 |
| Quick Ratio | 13.64 |
| Solvency Ratio | -2.297 |
| Cash Ratio | 6.64 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-10.86
Peers avg: 27.8
|
| PEG Ratio | -0.16 |
| Forward PEG | -0.16 |
| Price/Book | 5.38 |
| Price/Sales | 0.00 |
| Price/FCF | -13.46 |
| Price/Op Cash Flow | -13.49 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1052 |
| Debt/Equity | 0.1279 |
| Debt/Capital | 0.1134 |
| Long-Term Debt/Capital | 0.1127 |
| Financial Leverage | 1.22 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -4.510 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -36.09 |
| Interest Coverage | -41.8899 |
| Short-Term Operating Cash Flow Coverage | -439.17 |
| Operating Cash Flow Coverage | -3.12 |
| Capital Expenditure Coverage | -382.70 |
| Dividend + Capital Expenditure Coverage | -382.70 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -4.664 |
| Debt/Share | 1.3208 |
| Cash/Share | 11.12 |
| Book Value/Share | 9.41 |
| Tangible BV/Share | 9.41 |
| Equity/Share | 9.41 |
| Operating Cash Flow/Share | -3.754 |
| Capital Expenditure/Share | 0.010 |
| FCF/Share | -3.763 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.950 |
| Price/Fair Value | 5.38 |
| Debt/Market Cap | 0.0238 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -10.20 |